User:The Anome/Cancer dictionary test
Vapreotide
Vapreotide is a substance that is being studied in the treatment of cancer. It belongs to the family of drugs called somatostatin analogs.
External links
- Vapreotide entry in the public domain NCI Cancer Dictionary
Varenicline tartrate
Varenicline tartrate is a drug used to help people stop smoking by acting the same way nicotine acts in the brain. It is a type of nicotine receptor partial agonist. Also called Chantix.
External links
- Varenicline tartrate entry in the public domain NCI Cancer Dictionary
The trade name for varenicline tartrate is Champix and not chantix
Vascular endothelial growth factor-antisense oligonucleotide
Vascular endothelial growth factor-antisense oligonucleotide is a substance being studied in the treatment of Kaposi sarcoma. It is a type of antisense oligonucleotide. Also called VEGF-AS.
External links
- Vascular endothelial growth factor-antisense oligonucleotide entry in the public domain NCI Cancer Dictionary
Vatalanib
Vatalanib is a substance that is being studied in the treatment of cancer. It belongs to the families of drugs called protein tyrosine kinase inhibitors and VEGF receptor kinase inhibitors. Also called PTK787/ZK 222584.
External links
- Vatalanib entry in the public domain NCI Cancer Dictionary
VB4-845
VB4-845 is a substance being studied in the treatment of certain types of head and neck cancer. VB4-845 is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. It binds to EpCAM (a protein on the surface of epithelial cells and some types of cancer cells). Also called anti-EpCAM-Pseudomonas-exotoxin fusion protein and Proxinium.
External links
- VB4-845 entry in the public domain NCI Cancer Dictionary
VEGF Trap
VEGF Trap is a substance that blocks the action of vascular endothelial growth factor (VEGF), and prevents the growth of new blood vessels into a tumor. It belongs to the family of drugs called angiogenesis inhibitors.
External links
- VEGF Trap entry in the public domain NCI Cancer Dictionary
VEGF-AS
VEGF-AS is a substance being studied in the treatment of Kaposi sarcoma. It is a type of antisense oligonucleotide. Also called vascular endothelial growth factor-antisense oligonucleotide.
External links
- VEGF-AS entry in the public domain NCI Cancer Dictionary
Velafermin
Velafermin is a substance that is being studied in the prevention and treatment of oral mucositis (sores in the mouth) in patients receiving high-dose chemotherapy. Velafermin belongs to the family of drugs called recombinant human fibroblast growth factors (rhFGF).
External links
- Velafermin entry in the public domain NCI Cancer Dictionary
Venous sampling
Venous sampling is a procedure in which a sample of blood is taken from a certain vein and checked for specific substances released by nearby organs and tissues. A higher than normal amount of a substance can be a sign of disease in the organ or tissue that makes it.
External links
- Venous sampling entry in the public domain NCI Cancer Dictionary
Villous adenoma
Villous adenoma is a type of polyp that grows in the colon and other places in the gastrointestinal tract and sometimes in other parts of the body. These adenomas may become malignant (cancerous).
External links
- Villous adenoma entry in the public domain NCI Cancer Dictionary
Vinflunine
Vinflunine is a substance being studied in the treatment of bladder cancer, lung cancer, and other types of cancer. Also called Javlor.
External links
- Vinflunine entry in the public domain NCI Cancer Dictionary
Virulizin
Virulizin is a substance that activates some types of immune system cells, and is being studied as a treatment for cancer. It belongs to the family of drugs called biological therapy agents.
External links
- Virulizin entry in the public domain NCI Cancer Dictionary
Viscotoxin
Viscotoxin is a member of a group of small proteins produced by mistletoe plants that are able to kill cells and may stimulate the immune system.
External links
- Viscotoxin entry in the public domain NCI Cancer Dictionary
Visual pathway glioma
Visual pathway glioma is a rare, slow-growing tumor of the eye.
External links
- Visual pathway glioma entry in the public domain NCI Cancer Dictionary
Vitamin A acid
Vitamin A acid is a form of vitamin A that is made by the body, and can also be made in the laboratory. It is used to treat acute promyelocytic leukemia, usually together with other drugs, and to treat acne. It is being studied in the treatment and prevention of other types of cancer. Also called all-trans retinoic acid, ATRA, retinoic acid, and tretinoin.
External links
- Vitamin A acid entry in the public domain NCI Cancer Dictionary
VNP20009
VNP20009 is a genetically modified Salmonella bacterium that is injected into the tumor. It is being studied for its ability to shrink solid tumors.
External links
- VNP20009 entry in the public domain NCI Cancer Dictionary
VNP40101M
VNP40101M is a substance that is being studied as a treatment for cancer. It belongs to the family of drugs called alkylating agents.
External links
- VNP40101M entry in the public domain NCI Cancer Dictionary
VX 853
VX 853 is a drug being studied to make cancer cells less resistant to the effects of chemotherapy.
External links
- VX 853 entry in the public domain NCI Cancer Dictionary
VX-710
VX-710 is a drug being studied to make cancer cells less resistant to the effects of chemotherapy.
External links
- VX-710 entry in the public domain NCI Cancer Dictionary
Wedge resection
Wedge resection is a surgical procedure to remove a triangle-shaped slice of tissue. It may be used to remove a tumor and a small amount of normal tissue around it.
External links
- Wedge resection entry in the public domain NCI Cancer Dictionary
WGA study
WGA study is a study that compares the complete DNA of people with a disease or condition to the DNA of people without the disease or condition. These studies find the genes involved in a disease, and may help prevent, diagnose, and treat the disease. Also called whole genome association study.
External links
- WGA study entry in the public domain NCI Cancer Dictionary
Whole genome association study
Whole genome association study is a study that compares the complete DNA of people with a disease or condition to the DNA of people without the disease or condition. These studies find the genes involved in a disease, and may help prevent, diagnose, and treat the disease. Also called WGA study.
External links
- Whole genome association study entry in the public domain NCI Cancer Dictionary
Wilms tumor-aniridia-genitourinary anomalies-mental retardation syndrome
Wilms tumor-aniridia-genitourinary anomalies-mental retardation syndrome is a rare, genetic disorder that is present at birth and has two or more of the following symptoms: Wilms tumor (a type of kidney cancer); little or no iris (the colored part of the eye); defects in the sexual organs and urinary tract (the organs that make urine and pass it from the body); and below average mental ability. WAGR syndrome occurs when part of chromosome 11 is missing. Also called WAGR syndrome.
External links
- Wilms tumor-aniridia-genitourinary anomalies-mental retardation syndrome entry in the public domain NCI Cancer Dictionary
Wobe-Mugos E
Wobe-Mugos E is a mixture made from an extract of the calf thymus gland and enzymes (proteins that speed up chemical reactions in the body) from the papaya plant, the pancreas of cows, and the pancreas of pigs. It has been used in Europe as a treatment for a variety of cancers and for herpes virus infections.
External links
- Wobe-Mugos E entry in the public domain NCI Cancer Dictionary
Xerogram
Xerogram is a picture of the body recorded on paper rather than on film. Also called a xeroradiograph.
External links
- Xerogram entry in the public domain NCI Cancer Dictionary
Xeroradiograph
Xeroradiograph is a picture of the body recorded on paper rather than on film. Also called a xerogram.
External links
- Xeroradiograph entry in the public domain NCI Cancer Dictionary
Xeroradiography
Xeroradiography is a type of x-ray in which a picture of the body is recorded on paper rather than on film.
External links
- Xeroradiography entry in the public domain NCI Cancer Dictionary
XK469R
XK469R is a substance that is being studied in the treatment of leukemia. It belongs to the family of drugs called topoisomerase inhibitors.
External links
- XK469R entry in the public domain NCI Cancer Dictionary
XR9576
XR9576 is a substance that is being studied in the treatment of cancer. It may help tumor cells respond again to drugs they have become resistant (unable to respond) to. XR9576 belongs to the families of drugs called multidrug resistance inhibitors and P-glycoprotein antagonists. Also called tariquidar.
External links
- XR9576 entry in the public domain NCI Cancer Dictionary
XRP9881
XRP9881 is a substance that is being studied in the treatment of breast cancer. It belongs to the family of drugs called taxane derivatives.
External links
- XRP9881 entry in the public domain NCI Cancer Dictionary
Xyotax
Xyotax is a form of the anticancer drug paclitaxel combined with a protein called poliglumex that may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of breast cancer, ovarian cancer, lung cancer, and other types of cancer. It belongs to the family of drugs called mitotic inhibitors. Also called paclitaxel poliglumex, paclitaxel polyglutamate, and CT-2103.
External links
- Xyotax entry in the public domain NCI Cancer Dictionary
YM598
YM598 is a substance that is being studied as a treatment for advanced prostate cancer and for pain caused by prostate cancer that has spread to the bone. It belongs to the family of drugs called endothelin ETA receptor antagonists.
External links
- YM598 entry in the public domain NCI Cancer Dictionary
Yttrium Y 90 DOTA monoclonal antibody HuPAM4
Yttrium Y 90 DOTA monoclonal antibody HuPAM4 is a monoclonal antibody linked to a radioactive substance. It is being studied in the treatment of advanced pancreatic cancer. The monoclonal antibody called HuPAM4 is made in the laboratory and can locate and bind to pancreatic cancer cells. It is linked to a radioactive form of yttrium that can kill cancer cells without harming normal cells. Yttrium Y 90 DOTA monoclonal antibody HuPAM4 is a type of radioimmunoconjugate.
External links
- Yttrium Y 90 DOTA monoclonal antibody HuPAM4 entry in the public domain NCI Cancer Dictionary
Yttrium Y 90 DOTA-biotin
Yttrium Y 90 DOTA-biotin is a compound that contains the radioisotope yttrium Y 90 linked to the chemical biotin. Biotin is a molecule that binds strongly to the chemical streptavidin. Yttrium Y 90 DOTA-biotin will find tumor cells in the body that have been targeted by an antibody linked to streptavidin and kill them. It is being studied together with CC49-streptavidin in the treatment of cancer. Also called 90Y-DOTA-biotin.
External links
- Yttrium Y 90 DOTA-biotin entry in the public domain NCI Cancer Dictionary
ZD0473
ZD0473 is a substance that is being studied in the treatment of cancer. It belongs to the family of drugs called platinum analogs.
External links
- ZD0473 entry in the public domain NCI Cancer Dictionary
ZD4054
ZD4054 is a substance that is being studied in the treatment of prostate cancer. It belongs to the family of drugs called endothelin-receptor antagonists.
External links
- ZD4054 entry in the public domain NCI Cancer Dictionary